查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1464659

诊断专用抗体市场，按产品类型、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Diagnostic Specialty Antibodies Market, By Product Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年诊断专用抗体市场规模为279.1亿美元，2024年至2032年复合年增长率为5.23%。

诊断专用抗体市场-市场动态

传染病和慢性病发病率的上升预计将推动市场的成长

癌症、心血管疾病、糖尿病和自体免疫疾病等慢性疾病的盛行率正在增加。诊断专用抗体对于精确诊断和监测这些病症至关重要。美国疾病管制中心报告称，慢性病约占美国医疗保健费用的 75%，估计每人每年花费 5,300 美元。此外，随着新兴市场医疗保健基础设施的改善和医疗保健支出的增加，诊断专用抗体市场的全球扩张存在相当大的机会。然而，与这些抗体的开发和验证相关的高成本可能会阻碍市场成长。

诊断专用抗体市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 5.23% 左右的复合年增长率成长

根据产品类型细分，预计单株抗体将在 2023 年呈现最大市场份额

从应用细分来看，2023年传染病诊断为主导类型

根据最终用户细分，医院是 2023 年的领先类型

按地区划分，北美是 2023 年的主要收入来源

诊断专用抗体市场-細項分析：

全球诊断专用抗体市场根据产品类型、应用、最终用户和地区进行细分。

根据产品类型，市场分为三类：单株抗体、多株抗体株抗体和重组多株抗体抗体。单株抗体在市场上占有最大份额。单株抗体在诊断专用抗体市场中至关重要，可为各种诊断目的提供卓越的特异性和重现性。

根据应用，市场分为六个部分：肝炎诊断、结核病诊断、登革热诊断、肿瘤诊断、爱滋病毒诊断、传染病诊断等。传染病诊断在市场上占有最大份额。在传染病流行率上升、对快速精确诊断测试的需求不断增长以及抗体技术进步的推动下，诊断专用抗体的全球市场正在持续增长。

根据最终用户，市场分为两类：诊断实验室、医院、其他。医院是市场的主导力量。随着医院越来越多地采用尖端诊断技术和个人化医疗策略，对诊断专用抗体的需求预计将会上升，从而推动医疗保健诊断的进步和突破。

诊断专用抗体市场 - 地理洞察

从地理上看，该市场横跨北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些区域根据对商业活动有贡献的国家进一步细分。该市场主要由北美主导，这归因于其完善的医疗基础设施。该地区是全球医疗保健支出水准最高的地区之一，政府、私人保险公司和个人对医疗保健服务和产品进行了大量投资。 2022年，美国医疗保健支出成长4.1%，总计4.5兆美元，即人均13,493美元。根据国家医疗支出帐户 (NHEA) 的报告，美国的医疗支出占国内生产毛额的 17.3%。在自检试剂盒日益普及以及针对传染病的检测试剂盒的监管批准数量不断增加的推动下，欧洲将成为预测期内继北美之后市场成长的第二大地区。

诊断专用抗体市场-竞争格局：

在客製化抗体开发和生产服务市场中，该公司努力透过为诊断分析开发人员和研究人员提供个人化解决方案来脱颖而出。这些解决方案涵盖抗体设计、生产、纯化、缀合和验证等各个面向。供应商凭藉其技术专长、严格的品质保证措施和卓越的客户支援而脱颖而出。创新新创公司和生物技术公司不断推出新颖的抗体技术和诊断检测方法，进一步推动了市场的发展。这些公司可能专注于利基市场，满足新兴的诊断需求，或拥有专有的抗体平台。新创公司通常透过提供颠覆性技术、维持快速创新週期和采用灵活的商业模式来获得竞争优势。

最近的发展：

2020 年4 月17 日，罗氏宣布开发并即将发布其Elecsys 抗SARS-CoV-2 血清学测试，旨在识别曾接触过严重急性呼吸系统综合症冠状病毒2 (SARS-CoV-2) 的个体中的抗体导致 COVID-19 疾病的罪魁祸首。

FDA 本周向 Abbott 颁发了两项紧急使用授权 (EUA)，允许在该公司的 Alinity 系统上进行诊断和抗体测试。如今，该机构已授权雅培的 COVID-19 分子诊断测试在其新型 Alinity m 分子实验室仪器上使用。 Abbott 已开始向美国客户推出 Alinity m 系统。

目录

第 1 章：诊断专用抗体市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的诊断专用抗体市场片段
    • 诊断专用抗体市场片段（依应用）
    • 最终用户的诊断专用抗体市场片段
    • 按国家/地区分類的诊断专用抗体市场片段
    • 按地区分類的诊断专用抗体市场片段
  • 竞争洞察

第 3 章：诊断专用抗体主要市场趋势

  • 诊断专用抗体市场驱动因素
    • 市场驱动因素的影响分析
  • 诊断专用抗体市场限制
    • 市场限制影响分析
  • 诊断专用抗体市场机会
  • 诊断专用抗体市场未来趋势

第 4 章：诊断专用抗体产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：诊断专用抗体市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：诊断专用抗体市场格局

  • 诊断专用抗体市场占有率分析，2023 年
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：诊断专用抗体市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 单株抗体
    • 多株抗体抗体
    • 重组多株抗体抗体

第 8 章：诊断专用抗体市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 肝炎诊断
    • 结核病诊断
    • 登革热诊断
    • 肿瘤诊断
    • 爱滋病毒诊断
    • 传染病诊断
    • 其他的

第 9 章：诊断专用抗体市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 诊断实验室
    • 医院*
    • 其他的

第 10 章：诊断专用抗体市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美诊断专用抗体主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲诊断专用抗体主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区诊断专用抗体主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲诊断专用抗体主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲诊断专用抗体主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 诊断专用抗体产业

  • 竞争仪表板
  • 公司简介
    • F. Hoffmann- La Roche AG
    • Abcam PLC
    • Abbott Laboratories
    • Bio-Rad Laboratories Inc.
    • Agilent Technologies Inc.
    • Creative Diagnostics
    • Thermo Fisher Scientific Inc.
    • Becton, Dickinson and Company
    • Merck KGaA
    • Sartorius AG
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2461

REPORT HIGHLIGHT

Diagnostic Specialty Antibodies Market size was valued at USD 27,910 Million in 2023, expanding at a CAGR of 5.23% from 2024 to 2032.

Diagnostic specialty antibodies are a type of antibodies that have been specifically designed and are used for diagnostic purposes in different medical and scientific fields. These antibodies are highly precise in targeting their intended molecules, which allows for accurate detection and measurement. They typically recognize unique epitopes on the molecules they are targeting, ensuring that there is minimal interference from other substances. Diagnostic antibodies find applications in various diagnostic techniques such as enzyme-linked immunosorbent assay (ELISA), immunohistochemistry (IHC), western blotting, flow cytometry, and immunofluorescence. By helping to identify and quantify specific analytes in biological samples, these antibodies play a crucial role in the diagnosis and monitoring of diseases.

Diagnostic Specialty Antibodies Market- Market Dynamics

Rise in occurrence of Infectious and chronic diseases are expected to propel the growth of market

Chronic illnesses like cancer, cardiovascular diseases, diabetes, and autoimmune disorders are increasing in prevalence. Diagnostic specialty antibodies are essential for precise diagnosis and monitoring of these conditions. The Centers for Disease Control reports that chronic diseases contribute to approximately 75 percent of healthcare expenses in the United States, amounting to an estimated USD5300 per person per year. Additionally, as healthcare infrastructure improves and healthcare spending rises in emerging markets, there is considerable opportunity for the global expansion of the diagnostic specialty antibodies market. Nevertheless, the high costs associated with the development and validation of these antibodies may hinder market growth.

Diagnostic Specialty Antibodies Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.23% over the forecast period (2024-2032)

Based on product type segmentation, Monoclonal Antibodies was predicted to show maximum market share in the year 2023

Based on application segmentation, Infectious Disease Diagnostics was the leading type in 2023

Based on End User segmentation, Hospitals was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Diagnostic Specialty Antibodies Market- Segmentation Analysis:

The Global Diagnostic Specialty Antibodies Market is segmented on the basis of Product Type, Application, End-User, and Region.

The market is segmented into three categories according to product type: Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies. Monoclonal Antibodies hold the largest share in the market. Monoclonal antibodies are essential in the diagnostic specialty antibodies market, providing exceptional specificity and reproducibility for a wide range of diagnostic purposes.

The market is categorized into six segments based on application: Hepatitis Diagnostics, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, Infectious Disease Diagnostics, and Others. Infectious Disease Diagnostics holds the largest share in the market. The global market for diagnostic specialty antibodies is witnessing continuous growth, driven by the rising prevalence of infectious diseases, the rising need for quick and precise diagnostic tests, and advancements in antibody technology.

The market is segmented into two categories according to End-User: Diagnostic Laboratories, Hospitals, Others. Hospitals are the dominant force in the market. With hospitals increasingly embracing cutting-edge diagnostic technologies and personalized medicine strategies, the need for diagnostic specialty antibodies is projected to rise, fueling progress and breakthroughs in healthcare diagnostics.

Diagnostic Specialty Antibodies Market- Geographical Insights

Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. The market is predominantly led by North America, attributed to its well-established healthcare infrastructure. The region boasts one of the highest healthcare expenditure levels globally, with substantial investments from governments, private insurers, and individuals in healthcare services and products. In 2022, U.S. health care spending increased by 4.1 percent, totaling USD4.5 trillion or USD13,493 per capita. Health spending in the U.S. accounted for 17.3 percent of the nation's Gross Domestic Product, as reported by the National Health Expenditure Accounts (NHEA). Following North America, Europe emerges as the second-largest region for market growth during the forecast period, driven by the rising popularity of self-testing kits and the growing number of regulatory approvals for test kits targeting infectious diseases.

Diagnostic Specialty Antibodies Market- Competitive Landscape:

In the market for custom antibody development and production services, companies strive to stand out by offering personalized solutions to diagnostic assay developers and researchers. These solutions encompass various aspects such as antibody design, production, purification, conjugation, and validation. Providers distinguish themselves through their technical expertise, stringent quality assurance measures, and exceptional customer support. The market is further fueled by the presence of innovative startups and biotechnology firms that continuously introduce novel antibody technologies and diagnostic assays. These companies may specialize in niche markets, address emerging diagnostic needs, or possess proprietary antibody platforms. Startups often gain a competitive edge by offering disruptive technologies, maintaining rapid innovation cycles, and adopting flexible business models.

Recent Developments:

On April 17, 2020, Roche announced the development and forthcoming release of its Elecsys Anti-SARS-CoV-2 serology test designed to identify antibodies in individuals who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) responsible for causing the COVID-19 illness.

The FDA has issued two emergency use authorizations (EUAs) to Abbott this week, permitting diagnostic and antibody tests to be conducted on the company's Alinity systems. Nowadays, the agency granted authorization for Abbott's COVID-19 molecular diagnostic test to be used on its new Alinity m molecular laboratory instrument. Abbott has initiated the rollout of the Alinity m system to customers in the United States.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL Diagnostic Specialty Antibodies MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

F. Hoffmann- La Roche AG

Abcam PLC

Abbott Laboratories

Bio-Rad Laboratories Inc.

Agilent Technologies Inc.

Creative Diagnostics

Thermo Fisher Scientific Inc.

Becton, Dickinson and Company

Merck KGaA

Sartorius AG

Others

GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Polyclonal Antibodies

GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hepatitis Diagnostics
  • Tuberculosis Dignostics
  • Dengue DiaGnostic
  • Oncology Diagnostic
  • HIV Diagnostic
  • Infectious Disease Diagnostics
  • Others

GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET, BY End-User- MARKET ANALYSIS, 2019 - 2032

  • Diagnostic Laboratories
  • Hospitals*
  • Others

GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Diagnostic Specialty Antibodies Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Diagnostic Specialty Antibodies Market Snippet by Product Type
    • 2.1.2.Diagnostic Specialty Antibodies Market Snippet by Application
    • 2.1.3.Diagnostic Specialty Antibodies Market Snippet by End-User
    • 2.1.4.Diagnostic Specialty Antibodies Market Snippet by Country
    • 2.1.5.Diagnostic Specialty Antibodies Market Snippet by Region
  • 2.2.Competitive Insights

3.Diagnostic Specialty Antibodies Key Market Trends

  • 3.1.Diagnostic Specialty Antibodies Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Diagnostic Specialty Antibodies Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Diagnostic Specialty Antibodies Market Opportunities
  • 3.4.Diagnostic Specialty Antibodies Market Future Trends

4.Diagnostic Specialty Antibodies Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Diagnostic Specialty Antibodies Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Diagnostic Specialty Antibodies Market Landscape

  • 6.1.Diagnostic Specialty Antibodies Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Diagnostic Specialty Antibodies Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Monoclonal Antibodies
    • 7.1.3.Polyclonal Antibodies
    • 7.1.4.Recombinant Polyclonal Antibodies

8.Diagnostic Specialty Antibodies Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Hepatitis Diagnostics
    • 8.1.3.Tuberculosis Dignostics
    • 8.1.4.Dengue DiaGnostic
    • 8.1.5.Oncology Diagnostic
    • 8.1.6.HIV Diagnostic
    • 8.1.7.Infectious Disease Diagnostics
    • 8.1.8.Others

9.Diagnostic Specialty Antibodies Market - By End-User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2.Diagnostic Laboratories
    • 9.1.3.Hospitals*
    • 9.1.4.Others

10.Diagnostic Specialty Antibodies Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Diagnostic Specialty Antibodies Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Diagnostic Specialty Antibodies Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Diagnostic Specialty Antibodies Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Diagnostic Specialty Antibodies Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Diagnostic Specialty Antibodies Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Diagnostic Specialty Antibodies Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.F. Hoffmann- La Roche AG
    • 11.2.2.Abcam PLC
    • 11.2.3.Abbott Laboratories
    • 11.2.4.Bio-Rad Laboratories Inc.
    • 11.2.5.Agilent Technologies Inc.
    • 11.2.6.Creative Diagnostics
    • 11.2.7.Thermo Fisher Scientific Inc.
    • 11.2.8.Becton, Dickinson and Company
    • 11.2.9.Merck KGaA
    • 11.2.10.Sartorius AG
    • 11.2.11.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Diagnostic Specialty Antibodies Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Diagnostic Specialty Antibodies Market, by Product Type 2019-2032 (USD Million)
  • TABLE Diagnostic Specialty Antibodies Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Diagnostic Specialty Antibodies Market, by Application 2019-2032 (USD Million)
  • TABLE Diagnostic Specialty Antibodies Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Diagnostic Specialty Antibodies Market, by End-User 2019-2032 (USD Million)
  • TABLE Diagnostic Specialty Antibodies Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Diagnostic Specialty Antibodies Market, by Region 2019-2032 (USD Million)
  • TABLE North America Diagnostic Specialty Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Specialty Antibodies Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Specialty Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Specialty Antibodies Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Specialty Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Specialty Antibodies Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Specialty Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Specialty Antibodies Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Specialty Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Specialty Antibodies Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Specialty Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Specialty Antibodies Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Specialty Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Specialty Antibodies Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Specialty Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Specialty Antibodies Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Specialty Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Specialty Antibodies Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Specialty Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Specialty Antibodies Market, by End-User, 2019-2032 (USD Million)